promise nucleic acid base oligonucleotid effect gene therapy held back low bioavail poor cellular uptake target tissue upon system administer one strategy improv delivery use short cellpenetr peptide cpp either directly attach cargo coal linkage format noncoval nanoparticles complex facility review highlight recent proofofprincipl studi until strategy discus prospect translate approach clinic applied 